28
Oct
2025

Kindeva

Exhibitor at CPHI Frankfurt 2025 stand 5.0C8, Contract Manufacturing and Services
About Us

 

Kindeva Drug Delivery is a leading global powerhouse CDMO for sterile injectable, pulmonary, nasal, transdermal, and intradermal finished dose. We deliver unrivaled expertise across development, manufacturing, and comprehensive analytical services. Through strategic investments, we are expanding aseptic injectable fill-finish capabilities and leading the way in green propellants. Combining forces with a diverse global client base, Kindeva operates state-of-the-art facilities across the U.S. and U.K.  

 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2023
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
Contract Manufacturer
Packaging & drug delivery
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 5.0C8, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Analytical Services

    Product Analytical Services

    Our lab is efficiently run with currently little to no lead time. Some of the common testing services we can support out of our Woodbury, MN state-of-the-art laboratory are: • Method and Validation for clinical stage • Extractables and Leachables • Stability and storage • Container Closure Integrity Test...
  • Dermal: Microneedle and Transdermal patch technologies

    Product Dermal: Microneedle and Transdermal patch technologies

    Microneedle Technology: Development, clinical and commercial scale up. Potential room temperature stability, avoiding needle stick, easy to administer. Transdermal: Single-layer drug-in adhesive patches  Multi-layer drug-in adhesive patches  Active gel patch formulation (applied as a gel, dries to discre...
  • Inhalation- pMDI Green Propellent, Dry Powder, Soft Mist, Nebulizer

    Product Inhalation- pMDI Green Propellent, Dry Powder, Soft Mist, Nebulizer

    Early-stage device selection and formulation design through all stages of product testing and process development, cGMP scale-up, and commercialization 
  • Nasal Spray

    Product Nasal Spray

    From formulation development to commercial distribution in the US, 10 countries in Europe, and Australia 55,000 ft² (5,100 m²) of space on the Coldstream Research Campus in Lexington FDA/EMA-approved nasal spray production facility DEA-registered to manufacture and test controlled substances
  • Sterile Injectable Fill/Finish

    Product Sterile Injectable Fill/Finish

    Commercial and Clinical. State of the Art, fully Annex 1 compliant facility, 60 years of experience Four Isolator lines with infrastructure in place for up to eight lines 200,000 sq. ft. cGMP footprint 100M+ unit capacity across Vial, Syringes, and Cartridges Sterile injectable Fill/Finish and final assem...